FranzTWinklhoferMD

Associate Professor, Internal Medicine, University Kansas School of Medicine

Dr. Winklhofer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3901 Rainbow Blvd
# Stop
Kansas City, KS 66160
Phone+1 913-588-6074

Fax+1 913-588-3867

University of Kansas School of MedicineFellowship, Nephrology, 1994 - 1996
University of Kansas School of MedicineResidency, Internal Medicine, 1991 - 1994
University of Kansas School of MedicineClass of 1991

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

21 citations
Biological Efficacy and Safety of Niacinamide in Patients With ADPKD.
Mireille El Ters, Xia Zhou, Rebecca J. Lepping, Pengcheng Lu, Rainer T. Karcher
Kidney International Reports. 2020-06-10
335 citations
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier, Kaleab Z. Abebe, Ronald D. Perrone, Vicente E. Torres, William E. Braun
The New England Journal of Medicine. 2014-12-10
178 citations
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Kaleab Z. Abebe, Arlene B. Chapman, Robert W. Schrier, William E. Braun
The New England Journal of Medicine. 2014-12-10

Clinical Trial: HALT PKDNational Center For Research Resources2009
Clinical Trial: HALT PKDNational Center For Research Resources2008
HALT PKD (Halt Progression Of Polycystic Kidney Disease)National Center For Research Resources2007